Clinical Trials

A dramatic breakthrough in the rehabilitation of the paralyzed: The US Food and Drug Administration (FDA) has approved the design of the first human clinical trial for Matriself. Here are the details on the revolutionary technology poised to transform medical treatment.

A massive study examining dozens of side effects attributed to popular cholesterol-lowering drugs has found that only four are actually caused by the treatment.

Significant news in the fight against one of the deadliest cancers: a new oral drug has nearly doubled the median survival of patients with metastatic pancreatic cancer who had already received prior treatment, compared to standard chemotherapy. The drug, Daraxonrasib (RMC-6236), was tested in a phase 3 study called RASolute 302, showing a median overall survival of 13.2 months versus 6.7 months...

Developing a new drug is one of the most time-consuming and expensive processes in medicine. Despite billions in investment, many drugs fail during clinical trials. The Israeli startup QuantHealth has secured $45 million to expand its artificial intelligence platform, which aims to optimize the planning and execution of clinical trials.

QuantHealth, a company developing AI-based simulations for clinical trials, has raised $45 million in a Series B funding round. The total amount raised by the company has now reached $75 million.